NCT07708740 Two Intravenous Doses of Ketamine in Reducing the Oculocardiac Reflex in Adult Patients Undergoing Ophthalmic Surgery
| NCT ID | NCT07708740 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Ketamine |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-07-01 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate whether a lower dose of ketamine (0.5 mg/kg IV) may be as effective as a higher dose (0.75 mg/kg IV) in reducing oculocardiac reflex (OCR) incidence in adult patients undergoing ophthalmic surgery.
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 65 years old. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I, II. * Scheduled for elective ophthalmic surgery involving extraocular muscle traction under general anesthesia. Exclusion Criteria: * Ketamine contraindications (e.g., hypersensitivity, uncontrolled hypertension) * History of cardiac arrhythmia or conduction disorder * Glaucoma or raised intraocular pressure * ASA status greater than II * Patient refusal.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07708740 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Ketamine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07708740 currently recruiting?
Yes, NCT07708740 is actively recruiting participants. Contact the research team at drhebasalah593@gmail.com for enrollment information.
Where is the NCT07708740 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07708740 clinical trial?
NCT07708740 is sponsored by Cairo University. The trial plans to enroll 40 participants.